Company Overview

Update
Headquarters:
Manalapan, NJ
IPO:
Went Public on Jul 22, 2014
Stock:
TBRA
Categories:
Biotechnology
Description:
Tobira Therapeutics is engaged in research and development of compounds for treating life-threatening and life-altering infectious diseases.

Detailed Description

Update

Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.

Current Team (4)

Update

Past Team (1)

Update

Funding Rounds (4) - $55M

Update

Board Members and Advisors (4)

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    198 Route 9 North

    Suite 200

    Manalapan, NJ 07726

    USA